Article info

Download PDFPDF
Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

Authors

  1. Address correspondence and reprint requests to: Els Witteveen, MD, PhD, University Medical Centre Utrecht, Heidelberglaan 100, 3508 GA Utrecht, The Netherlands. Email: p.o.witteveen{at}umcutrecht.nl

Citation

Verhaar-Langereis M, Karakus A, Van Eijkeren M, et al
Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

Publication history

  • First published January 1, 2006.
Online issue publication 
January 01, 2006

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.